Clearside Biomedical Inc reports results for the quarter ended in March - Earnings Summary

Clearside Biomedical,

12/05/2022 16:06

* Clearside Biomedical Inc  CLSD.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue rose 920.6% to $347.00 thousand from a year ago; 
analysts expected $2.88 million. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was a
loss of 13 cents​.
    * The mean earnings estimate of analysts had risen by
about 21.2%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Clearside Biomedical Inc shares had fallen by 36.7% this
quarter and lost 47.3% so far this year.
    * The company reported a quarterly loss of $7.64 million.
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 03:05 p.m.  ​All
figures in US dollars unless otherwise stated